Progress towards generation of human haematopoietic stem cells

Nature Cell Biology

Volumn 18, Issue 11, 2016, Pages 1111-1117

  Wahlster, Lara ^a,b,c,d   Daley, George Q ^a,b,c  

^a BOSTON CHILDREN S HOSPITAL   (United States)

^b HARVARD MEDICAL SCHOOL   (United States)

^c HARVARD STEM CELL INSTITUTE   (United States)

^d UNIVERSITY HOSPITAL HEIDELBERG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

CHIMERIC ANTIGEN RECEPTOR; LONG UNTRANSLATED RNA; MICRORNA;

CELL ENGINEERING; CELL EXPANSION; CELL ISOLATION; CELL REPROGRAMMING TECHNIQUE; CELLS BY BODY ANATOMY; DIRECT CONVERSION; DISEASE MODEL; ERYTHROCYTE; HEMATOPOIESIS; HEMATOPOIETIC STEM CELL; HUMAN; IN VITRO STUDY; IN VIVO STUDY; INDUCED PLURIPOTENT STEM CELL; MECHANOTRANSDUCTION; MYELOMONOCYTIC CELL; NONHUMAN; NUCLEAR REPROGRAMMING; ONTOGENY; PRIORITY JOURNAL; PROCEDURES CONCERNING CELLS; REVIEW; T LYMPHOCYTE; TERATOMA; THROMBOCYTE; TISSUE ENGINEERING; BIOLOGICAL THERAPY; CELL DIFFERENTIATION; CYTOLOGY; EMBRYONIC STEM CELL; PHYSIOLOGY; PLURIPOTENT STEM CELL; REGENERATIVE MEDICINE;

CELL DIFFERENTIATION; CELL- AND TISSUE-BASED THERAPY; EMBRYONIC STEM CELLS; HEMATOPOIETIC STEM CELLS; HUMANS; PLURIPOTENT STEM CELLS; REGENERATIVE MEDICINE;

EID: 84990946188     PISSN: 14657392     EISSN: 14764679     Source Type: Journal    
DOI: 10.1038/ncb3419     Document Type: Review

References (87)

1. Orkin, S. H. & Zon, L. I. Hematopoiesis: an evolving paradigm for stem cell biology. Cell 132, 631-644 (2008).
2. Gragert, L. et al. HLA match likelihoods for hematopoietic stem-cell grafts in the U. S. registry. New Engl. J. Med. 371, 339-348 (2014).
3. Walasek, M. A., van Os, R. & de Haan, G. Hematopoietic stem cell expansion: challenges and opportunities. Ann. NY Acad. Sci. 1266, 138-150 (2012).
4. Fares, I. et al. Pyrimidoindole derivatives are agonists of human hematopoietic stem cell self-renewal. Science 345, 1509-1512 (2014).
5. Gao, Y. et al. Small-molecule inhibitors targeting INK4 protein p18(INK4C) enhance ex vivo expansion of haematopoietic stem cells. Nat. Commun. 6, 6328 (2015).
6. Qu, Q. et al. Endothelial progenitor cells promote efficient ex vivo expansion of cord blood-derived hematopoietic stem/progenitor cells. Cytotherapy 18, 452-464 (2016).
7. Thomson, J. A. et al. Embryonic stem cell lines derived from human blastocysts. Science 282, 1145-1147 (1998).
8. Takahashi, K. et al. Induction of pluripotent stem cells from adult human fibroblasts by defined factors. Cell 131, 861-872 (2007).
9. Park, I. H. et al. Reprogramming of human somatic cells to pluripotency with defined factors. Nature 451, 141-146 (2008).
10. Slukvin, I. I. Hematopoietic specification from human pluripotent stem cells: current advances and challenges toward de novo generation of hematopoietic stem cells. Blood 122, 4035-4046 (2013).
11. Vo, L. T. & Daley, G. Q. De novo generation of HSCs from somatic and pluripotent stem cell sources. Blood 125, 2641-2648 (2015).
12. Ebina, W. & Rossi, D. J. Transcription factor-mediated reprogramming toward hematopoietic stem cells. EMBO J. 34, 694-709 (2015).
13. Daniel, M. G., Pereira, C. F., Lemischka, I. R. & Moore, K. A. Making a hematopoietic stem cell. Trends Cell Biol. 26, 202-214 (2016).
14. Amabile, G. et al. In vivo generation of transplantable human hematopoietic cells from induced pluripotent stem cells. Blood 121, 1255-1264 (2013).
15. Suzuki, N. et al. Generation of engraftable hematopoietic stem cells from induced pluripotent stem cells by way of teratoma formation. Mol. Ther. 21, 1424-1431 (2013).
16. Ema, H. et al. Quantification of self-renewal capacity in single hematopoietic stem cells from normal and Lnk-deficient mice. Dev. Cell 8, 907-914 (2005).
17. Murry, C. E. & Keller, G. Differentiation of embryonic stem cells to clinically relevant populations: lessons from embryonic development. Cell 132, 661-680 (2008).
18. Kardel, M. D. & Eaves, C. J. Modeling human hematopoietic cell development from pluripotent stem cells. Exp. Hematol. 40, 601-611 (2012).
19. Sauvageau, G. et al. Differential expression of homeobox genes in functionally distinct CD34+ subpopulations of human bone marrow cells. Proc. Natl Acad. Sci. USA 91, 12223-12227 (1994).
20. Kyba, M., Perlingeiro, R. C. & Daley, G. Q. HoxB4 confers definitive lymphoid-myeloid engraftment potential on embryonic stem cell and yolk sac hematopoietic progenitors. Cell 109, 29-37 (2002).
21. Wang, L. et al. Generation of hematopoietic repopulating cells from human embryonic stem cells independent of ectopic HOXB4 expression. J. Exp. Med. 201, 1603-1614 (2005).
22. Ledran, M. H. et al. Efficient hematopoietic differentiation of human embryonic stem cells on stromal cells derived from hematopoietic niches. Cell Stem Cell 3, 85-98 (2008).
23. Pick, M., Azzola, L., Mossman, A., Stanley, E. G. & Elefanty, A. G. Differentiation of human embryonic stem cells in serum-free medium reveals distinct roles for bone morphogenetic protein 4, vascular endothelial growth factor, stem cell factor, and fibroblast growth factor 2 in hematopoiesis. Stem Cells 25, 2206-2214 (2007).
24. Chadwick, K. et al. Cytokines and BMP-4 promote hematopoietic differentiation of human embryonic stem cells. Blood 102, 906-915 (2003).
25. Keller, G., Kennedy, M., Papayannopoulou, T. & Wiles, M. V. Hematopoietic commitment during embryonic stem cell differentiation in culture. Mol. Cell. Biol. 13, 473-486 (1993).
26. Matsuoka, S. et al. Generation of definitive hematopoietic stem cells from murine early yolk sac and paraaortic splanchnopleures by aorta-gonad-mesonephros region-derived stromal cells. Blood 98, 6-12 (2001).
27. Clarke, R. L., Robitaille, A. M., Moon, R. T. & Keller, G. A. Quantitative proteomic analysis of hemogenic endothelium reveals differential regulation of hematopoiesis by SOX17. Stem Cell Rep. 5, 291-304 (2015).
28. Kennedy, M. et al. T lymphocyte potential marks the emergence of definitive hematopoietic progenitors in human pluripotent stem cell differentiation cultures. Cell Rep. 2, 1722-1735 (2012).
29. Sturgeon, C. M., Ditadi, A., Awong, G., Kennedy, M. & Keller, G. Wnt signaling controls the specification of definitive and primitive hematopoiesis from human pluripotent stem cells. Nat. Biotechnol. 32, 554-561 (2014).
30. Medvinsky, A. & Dzierzak, E. Definitive hematopoiesis is autonomously initiated by the AGM region. Cell 86, 897-906 (1996).
31. Boisset, J. C. et al. In vivo imaging of haematopoietic cells emerging from the mouse aortic endothelium. Nature 464, 116-120 (2010).
32. Eilken, H. M., Nishikawa, S. & Schroeder, T. Continuous single-cell imaging of blood generation from haemogenic endothelium. Nature 457, 896-900 (2009).
33. Ditadi, A. et al. Human definitive haemogenic endothelium and arterial vascular endothelium represent distinct lineages. Nat. Cell Biol. 17, 580-591 (2015).
34. Souilhol, C. et al. Inductive interactions mediated by interplay of asymmetric signalling underlie development of adult haematopoietic stem cells. Nat. Commun. 7, 10784 (2016).
35. Choi, K. D., Vodyanik, M. A. & Slukvin, I. I. Generation of mature human myelomonocytic cells through expansion and differentiation of pluripotent stem cell-derived lin-CD34+CD43+CD45+ progenitors. J. Clin. Invest. 119, 2818-2829 (2009).
36. Davis, R. L., Weintraub, H. & Lassar, A. B. Expression of a single transfected cDNA converts fibroblasts to myoblasts. Cell 51, 987-1000 (1987).
37. Morris, S. A. et al. Dissecting engineered cell types and enhancing cell fate conversion via CellNet. Cell 158, 889-902 (2014).
38. Sandler, V. M., Lailler, N. & Bouhassira, E. E. Reprogramming of embryonic human fibroblasts into fetal hematopoietic progenitors by fusion with human fetal liver CD34+ cells. PLoS ONE 6, e18265 (2011).
39. Szabo, E. et al. Direct conversion of human fibroblasts to multilineage blood progenitors. Nature 468, 521-526 (2010).
40. Mitchell, R. et al. Molecular evidence for OCT4-induced plasticity in adult human fibroblasts required for direct cell fate conversion to lineage specific progenitors. Stem Cells 32, 2178-2187 (2014).
41. Pulecio, J. et al. Conversion of human fibroblasts into monocyte-like progenitor cells. Stem Cells 32, 2923-2938 (2014).
42. Pereira, C. F. et al. Induction of a hemogenic program in mouse fibroblasts. Cell Stem Cell 13, 205-218 (2013).
43. Batta, K., Florkowska, M., Kouskoff, V. & Lacaud, G. Direct reprogramming of murine fibroblasts to hematopoietic progenitor cells. Cell Rep. 9, 1871-1884 (2014).
44. Elcheva, I. et al. Direct induction of haematoendothelial programs in human pluripotent stem cells by transcriptional regulators. Nat. Commun. 5, 4372 (2014).
45. Sandler, V. M. et al. Reprogramming human endothelial cells to haematopoietic cells requires vascular induction. Nature 511, 312-318 (2014).
46. Riddell, J. et al. Reprogramming committed murine blood cells to induced hematopoietic stem cells with defined factors. Cell 157, 549-564 (2014).
47. Doulatov, S. et al. Induction of multipotential hematopoietic progenitors from human pluripotent stem cells via respecification of lineage-restricted precursors. Cell Stem Cell 13, 459-470 (2013).
48. Kaufman, D. S. Toward clinical therapies using hematopoietic cells derived from human pluripotent stem cells. Blood 114, 3513-3523 (2009).
49. Olivier, E. N., Qiu, C., Velho, M., Hirsch, R. E. & Bouhassira, E. E. Large-scale production of embryonic red blood cells from human embryonic stem cells. Exp. Hematol. 34, 1635-1642 (2006).
50. Giarratana, M. C. et al. Proof of principle for transfusion of in vitro-generated red blood cells. Blood 118, 5071-5079 (2011).
51. Migliaccio, A. R., Whitsett, C., Papayannopoulou, T. & Sadelain, M. The potential of stem cells as an in vitro source of red blood cells for transfusion. Cell Stem Cell 10, 115-119 (2012).
52. Lee, H. Y. et al. PPAR and glucocorticoid receptor synergize to promote erythroid progenitor self-renewal. Nature 522, 474-477 (2015).
53. Rousseau, G. F., Giarratana, M. C. & Douay, L. Large-scale production of red blood cells from stem cells: what are the technical challenges ahead? Biotechnol. J. 9, 28-38 (2014).
54. Chang, C. J. et al. Production of embryonic and fetal-like red blood cells from human induced pluripotent stem cells. PLoS ONE 6, e25761 (2011).
55. Giani, F. C. et al. Targeted application of human genetic variation can improve red blood cell production from stem cells. Cell Stem Cell 18, 73-78 (2016).
56. Shi, J. et al. Engineered red blood cells as carriers for systemic delivery of a wide array of functional probes. Proc. Natl Acad. Sci. USA 111, 10131-10136 (2014).
57. Takayama, N. et al. Generation of functional platelets from human embryonic stem cells in vitro via ES-sacs, VEGF-promoted structures that concentrate hematopoietic progenitors. Blood 111, 5298-5306 (2008).
58. Lu, S. J. et al. Platelets generated from human embryonic stem cells are functional in vitro and in the microcirculation of living mice. Cell Res. 21, 530-545 (2011).
59. Nakamura, S. et al. Expandable megakaryocyte cell lines enable clinically applicable generation of platelets from human induced pluripotent stem cells. Cell Stem Cell 14, 535-548 (2014).
60. Liu, Y. et al. Efficient generation of megakaryocytes from human induced pluripotent stem cells using food and drug administration-approved pharmacological reagents. Stem Cells Transl. Med. 4, 309-319 (2015).
61. Zhang, N. et al. CRISPR/Cas9-mediated conversion of human platelet alloantigen allotypes. Blood 127, 675-680 (2015).
62. Lachmann, N. et al. Large-scale hematopoietic differentiation of human induced pluripotent stem cells provides granulocytes or macrophages for cell replacement therapies. Stem Cell Rep. 4, 282-296 (2015).
63. Timmermans, F. et al. Generation of T cells from human embryonic stem cell-derived hematopoietic zones. J. Immunol. 182, 6879-6888 (2009).
64. Themeli, M., Riviere, I. & Sadelain, M. New cell sources for T cell engineering and adoptive immunotherapy. Cell Stem Cell 16, 357-366 (2015).
65. Smith, M. J. et al. In vitro T-cell generation from adult, embryonic, and induced pluripotent stem cells: many roads to one destination. Stem Cells 33, 3174-3180 (2015).
66. Themeli, M. et al. Generation of tumor-targeted human T lymphocytes from induced pluripotent stem cells for cancer therapy. Nat. Biotechnol. 31, 928-933 (2013).
67. Agarwal, S. et al. Telomere elongation in induced pluripotent stem cells from dyskeratosis congenita patients. Nature 464, 292-296 (2010).
68. Park, I. H. et al. Disease-specific induced pluripotent stem cells. Cell 134, 877-886 (2008).
69. Hanna, J. et al. Treatment of sickle cell anemia mouse model with iPS cells generated from autologous skin. Science 318, 1920-1923 (2007).
70. Jeong, M. et al. Large conserved domains of low DNA methylation maintained by Dnmt3a. Nat. Genet. 46, 17-23 (2014).
71. Alvarez-Dominguez, J. R., Hu, W., Gromatzky, A. A. & Lodish, H. F. Long noncoding RNAs during normal and malignant hematopoiesis. Int. J. Hematol. 99, 531-541 (2014).
72. O'Connell, R. M. Endogenous miR-29a regulates HSC function in mammals. Blood 125, 2180-2181 (2015).
73. Roy, L. et al. MiR-24 is required for hematopoietic differentiation of mouse embryonic stem cells. PLoS Genet. 11, e1004959 (2015).
74. Copley, M. R. et al. The Lin28b-let-7-Hmga2 axis determines the higher self-renewal potential of fetal haematopoietic stem cells. Nat. Cell Biol. 15, 916-925 (2013).
75. Nimmo, R. et al. MiR-142-3p controls the specification of definitive hemangioblasts during ontogeny. Dev. Cell 26, 237-249 (2013).
76. Adamo, L. et al. Biomechanical forces promote embryonic haematopoiesis. Nature 459, 1131-1135 (2009).
77. North, T. E. et al. Hematopoietic stem cell development is dependent on blood flow. Cell 137, 736-748 (2009).
78. Lee, H. J., Li, N., Evans, S. M., Diaz, M. F. & Wenzel, P. L. Biomechanical force in blood development: extrinsic physical cues drive pro-hematopoietic signaling. Differentiation 86, 92-103 (2013).
79. Kim, P. G. et al. Flow-induced protein kinase A-CREB pathway acts via BMP signaling to promote HSC emergence. J. Exp. Med. 212, 633-648 (2015).
80. Diaz, M. F. et al. Biomechanical forces promote blood development through prostaglandin E2 and the cAMP-PKA signaling axis. J. Exp. Med. 212, 665-680 (2015).
81. Torisawa, Y. S. et al. Bone marrow-on-a-chip replicates hematopoietic niche physiology in vitro. Nat. Methods 11, 663-669 (2014).
82. Huh, D. et al. Reconstituting organ-level lung functions on a chip. Science 328, 1662-1668 (2010).
83. Cahan, P. et al. CellNet: network biology applied to stem cell engineering. Cell 158, 903-915 (2014).
84. Gori, J. L. et al. Vascular niche promotes hematopoietic multipotent progenitor formation from pluripotent stem cells. J. Clin. Invest. 125, 1243-1254 (2015).
85. Kobari, L. et al. Human induced pluripotent stem cells can reach complete terminal maturation: in vivo and in vitro evidence in the erythropoietic differentiation model. Haematologica 97, 1795-1803 (2012).
86. Dias, J. et al. Generation of red blood cells from human induced pluripotent stem cells. Stem Cells Dev. 20, 1639-1647 (2011).
87. Choi, K. D., Vodyanik, M. & Slukvin, I. I. Hematopoietic differentiation and production of mature myeloid cells from human pluripotent stem cells. Nat. Protoc. 6, 296-313 (2011).